Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Dysmenorrhoea, Heavy menstrual bleeding, SARS-CoV-2 test
Clinical narrative: Bleeding for 20 days. Once her period started again, it did not stop; Sometimes heavy flow with several medium sized clots a day; Some slight soreness/cramping; Some slight soreness/cramping; She did not have a period for 65 days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Dec2021 (Lot number: 33130BA) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. Relevant medical history included: "Sulfonamide allergy" (unspecified if ongoing); "Shrimp allergy" (unspecified if ongoing). The patient had not experienced Covid-19 prior vaccination. Concomitant medication(s) included: SERTRALINE. Vaccination history included: Bnt162b2 (First dose, Lot. EW0170. Location of injection: arm left), administration date: 22Apr2021, when the patient was 38 years old, for COVID-19 immunization; Bnt162b2 (Second dose, Lot. EW0187), administration date: 27May2021, when the patient was 38 years old, for COVID-19 immunization. The following information was reported: HEAVY MENSTRUAL BLEEDING (medically significant), outcome "unknown", described as "Bleeding for 20 days. Once her period started again, it did not stop"; HEAVY MENSTRUAL BLEEDING (non-serious), outcome "unknown", described as "Sometimes heavy flow with several medium sized clots a day"; DYSMENORRHOEA (non-serious), DYSMENORRHOEA (non-serious), outcome "unknown" and all described as "Some slight soreness/cramping"; AMENORRHOEA (non-serious), outcome "unknown", described as "She did not have a period for 65 days". The events "bleeding for 20 days. once her period started again, it did not stop", "sometimes heavy flow with several medium sized clots a day", "some slight soreness/cramping" and "she did not have a period for 65 days" were evaluated at the physician office visit.   Clinical course was the following: patient's period completely changed after receiving her booster shot. Her last cycle ended on the 28Dec2021, the day she got her booster, and then she did not have a period for 65 days. Once her period started again, it did not stop. She had been bleeding for 20 days. Sometimes heavy flow with several medium sized clots a day and some slight soreness/cramping. There were no signs of her cycle changing before the booster. She contacted her doctor to check in and to schedule an appointment at the beginning of the week.   Post the vaccination, the patient has been tested for COVID-19. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (19Mar2022) negative, notes: Abbot BinaxNOW Antigen Self Test, Nasal Swab; (08Feb2022) negative, notes: iHealth Antigen Rapid Test, Nasal Swab; (04Jan2022) negative, notes: SARS-CoV-2 RNA (NAA/RT-PCR)(NAA), Nasal Swab. It was unknown if therapeutic measures were taken as a result of heavy menstrual bleeding, heavy menstrual bleeding, dysmenorrhoea, dysmenorrhoea, amenorrhoea.